MedSina
Health library › Evidence-based

Understanding Microinvasive Glaucoma Surgery and Recovery

November 4, 2026·5 min read ·MedSina Evidence · PubMed

Microinvasive Glaucoma Surgery (MIGS) offers a range of innovative procedures designed to lower intraocular pressure with smaller incisions, often leading to quicker recovery times and reduced reliance on daily eye drops.

Understanding Microinvasive Glaucoma Surgery and Recovery

Understanding Glaucoma and Treatment Approaches

Glaucoma is a group of eye conditions that damage the optic nerve, often due to abnormally high pressure inside the eye. It is a neurodegenerative optic neuropathy and a leading cause of irreversible vision loss [2]. The primary goal of glaucoma treatment is to lower intraocular pressure (IOP) to prevent further damage to the optic nerve and preserve vision. Treatment options range from daily eye drops and laser procedures to various surgical interventions [2].

In recent years, Microinvasive Glaucoma Surgery (MIGS) has emerged as a significant advancement in the surgical management of glaucoma. The American Glaucoma Society (AGS), a leading professional society for glaucoma subspecialists, convened a task force of experts to provide a comprehensive overview of these procedures, addressing common questions and misconceptions [1].

What is Microinvasive Glaucoma Surgery (MIGS)?

MIGS refers to a category of surgical procedures designed to reduce intraocular pressure using microscopic instruments and tiny incisions. These procedures are generally characterized by their minimally invasive nature, which often translates to a favorable safety profile and potentially faster recovery compared to traditional glaucoma surgeries [1]. Unlike older, more invasive procedures like trabeculectomy or tube shunt surgery, MIGS aims to minimize tissue disruption and often works by enhancing the eye's natural fluid drainage pathways [1].

Many MIGS procedures are performed in conjunction with cataract surgery, allowing patients to address both conditions in a single operation. The precision required for these fine surgical maneuvers, especially in the delicate angles and spaces within the eye, can be enhanced by technologies like intra-operative optical coherence tomography (iOCT), which provides real-time, high-resolution imaging during surgery [3].

How MIGS Works to Lower Eye Pressure

MIGS procedures primarily work by improving the outflow of aqueous humor, the fluid inside the eye, thereby reducing intraocular pressure. While specific techniques vary, most MIGS devices and procedures target different parts of the eye's natural drainage system, such as the trabecular meshwork or Schlemm's canal, to facilitate fluid exit [1]. Some procedures might also aim to reduce the production of aqueous humor. The choice of a particular MIGS procedure depends on several factors, including the type and severity of glaucoma, the patient's overall eye health, and whether cataract surgery is also being performed [1].

Recovery and Post-Operative Care After MIGS

One of the key advantages of MIGS procedures is the potential for a quicker and less complicated recovery period compared to more traditional glaucoma surgeries [1]. Patients typically experience less post-operative discomfort and inflammation. Immediately after surgery, patients might notice mild irritation, redness, or temporary blurry vision. Your ophthalmologist will provide specific instructions for post-operative care, which usually includes using prescribed eye drops to prevent infection and control inflammation [1].

Follow-up appointments are crucial to monitor eye pressure and ensure proper healing. While individual recovery times can vary, many patients are able to resume their normal daily activities relatively quickly. It is important to follow all post-operative instructions carefully to achieve the best possible outcome and to attend all scheduled follow-up visits [1].

MIGS in the Landscape of Glaucoma Treatment

MIGS represents an important option in the continuum of glaucoma care. For many patients, initial treatment involves medication, often in the form of daily eye drops, or laser therapy such as Selective Laser Trabeculoplasty (SLT) [4]. SLT has been shown to provide intraocular pressure control comparable to medication-first therapy, significantly reducing the burden of daily drops [4]. In one study, approximately 70% of patients initially treated with SLT remained free from topical therapy and incisional surgery after six years [4]. Repeat SLT has also demonstrated similar efficacy to initial treatment without increased adverse events [6].

MIGS procedures are often considered when medical therapy or laser treatments are insufficient to control eye pressure, or when patients experience difficulties with adherence or side effects from eye drops. They can also be a suitable option for patients undergoing cataract surgery who also have mild to moderate glaucoma [1]. Research is also exploring the broader systemic implications of glaucoma treatment; for instance, visual impairment has been identified as a modifiable risk factor for dementia, and studies are investigating how different glaucoma management modalities, including surgery versus medical therapy, might influence long-term systemic outcomes such like dementia risk [2].

Important Considerations and Future Directions

It is important to understand that MIGS, like other glaucoma treatments, aims to manage the condition and prevent further vision loss, but it is not a cure [1]. Regular follow-up with an ophthalmologist is essential to monitor eye pressure and overall eye health after any glaucoma procedure. Patients should discuss all treatment options with their doctor to determine the most appropriate approach for their individual needs [1].

The field of glaucoma treatment continues to evolve rapidly. Beyond current surgical techniques, advancements in regenerative medicine, cell therapy, and 3D bioprinting are being explored for their potential to address neurodegeneration and restore lost visual function in glaucoma and other retinal diseases [8]. These emerging therapies hold promise for future breakthroughs in managing this complex condition.

Sources

glaucomaMIGSeye surgeryintraocular pressureophthalmologyrecovery

This article summarises published research for a general audience. It is not medical advice — talk to a qualified clinician about your own situation. Need help finding one? Browse doctors.